FAIRFIELD PMS — All Prescriptions & Medications — Page 8
Practice Code: G83044 | LONDON, SE7 8TX
Showing results 351-400 of 598
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 41 | 600 | £381 | -4.9% ▼ | |
| Hydrocortisone | 40 | 1,009 | £261 | -47.3% ▼ |
| Vardenafil | 40 | 328 | £636 | +186.5% ▲ |
| Glycopyrronium bromide | 39 | 13.4K | £14.8K | +90.0% ▲ |
| Erythromycin | 39 | 3,568 | £1.3K | +12.6% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 39 | 1,365 | £740 | +51.8% ▲ |
| Emollient bath and shower preparations | 39 | 11.6K | £168 | -37.9% ▼ |
| Eletriptan | 38 | 372 | £1.3K | +284.9% ▲ |
| Powder amino acid formula (0913107) | 38 | 160.0K | £10.1K | +15.1% ▲ |
| 37 | 4,400 | £199 | -71.8% ▼ | |
| Valsartan | 36 | 2,744 | £646 | -38.9% ▼ |
| Phenobarbital | 36 | 2,148 | £343 | +17.1% ▲ |
| Etoricoxib | 36 | 1,932 | £384 | -55.3% ▼ |
| Metronidazole | 36 | 1,435 | £514 | -4.2% ▼ |
| Diclofenac sodium | 35 | 2,030 | £252 | -31.1% ▼ |
| 35 | 1,637 | £296 | -29.2% ▼ | |
| Tirzepatide | 34 | 36 | £3.5K | -82.5% ▼ |
| Alprostadil | 34 | 124 | £1.4K | +98.8% ▲ |
| 34 | 683 | £389 | -13.7% ▼ | |
| Naratriptan hydrochloride | 33 | 372 | £72 | +26.2% ▲ |
| Testosterone | 33 | 3,414 | £1.7K | -56.8% ▼ |
| Adapalene | 33 | 1,710 | £594 | +50.8% ▲ |
| Bezafibrate | 32 | 2,242 | £409 | -40.6% ▼ |
| Acetylcysteine | 32 | 330 | £2.7K | +215.8% ▲ |
| 32 | 5,300 | £131 | -54.1% ▼ | |
| Tiotropium bromide/olodaterol | 31 | 41 | £1.3K | -49.5% ▼ |
| Exemestane | 31 | 370 | £181 | -4.6% ▼ |
| Oral rehydration salts | 31 | 5,226 | £2.2K | +7.3% ▲ |
| Travoprost | 30 | 145 | £91 | -36.3% ▼ |
| Timolol and travoprost | 30 | 133 | £635 | -7.2% ▼ |
| 30 | 3,420 | £867 | +55.2% ▲ | |
| Sotalol hydrochloride | 29 | 3,696 | £115 | -58.8% ▼ |
| Itraconazole | 29 | 955 | £493 | +116.2% ▲ |
| Azelastine hydrochloride | 29 | 232 | £177 | +144.0% ▲ |
| Cocois | 29 | 2,600 | £407 | +111.2% ▲ |
| Amorolfine hydrochloride | 29 | 158 | £211 | +25.6% ▲ |
| 29 | 2,750 | £76 | +124.8% ▲ | |
| 29 | 6,330 | £9.8K | +57.6% ▲ | |
| 29 | 95 | £225 | -28.8% ▼ | |
| Oxycodone hydrochloride/naloxone hydrochloride | 28 | 1,456 | £2.1K | +61.5% ▲ |
| Mycophenolate mofetil | 28 | 5,640 | £2.6K | -30.8% ▼ |
| Methylprednisolone acetate | 28 | 31 | £201 | -75.8% ▼ |
| 28 | 3,030 | £6.3K | -42.5% ▼ | |
| 28 | 4,720 | £971 | -28.1% ▼ | |
| 28 | 720 | £1.7K | +36.6% ▲ | |
| Fenofibrate | 27 | 986 | £102 | -72.1% ▼ |
| Erythromycin ethylsuccinate | 27 | 3,100 | £269 | +15.6% ▲ |
| Dulaglutide | 27 | 148 | £2.7K | -76.4% ▼ |
| Glucose | 27 | 3,530 | £320 | -48.1% ▼ |
| Betamethasone sodium phosphate | 27 | 3,086 | £404 | +119.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.